Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
41.12    -1.44 (-3.38%)
Bid:
41.06
Ask:
43.48
Spread: 2.42 (5.894%)
Market Cap: £416.42m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

Director/PDMR Shareholding

27 Jun 2019 16:58

RNS Number : 7227D
Aston Martin Lagonda Global Hld PLC
27 June 2019
 

27 June 2019

Aston Martin Lagonda Global Holdings plc

 

Notification of transactions by Directors, Persons Discharging Managerial Responsibilities ("PDMRs") and persons closely associated with them

 

Aston Martin Lagonda Global Holdings plc (the "Company") announces the following transactions by Directors in the Ordinary Shares in the Company ("Shares"), which took

place on 27 June 2019.

 

In accordance with the rules of the Aston Martin Lagonda Long-Term Incentive Plan 2018 ("LTIP"), the Directors named below were granted nil-cost options over Shares as follows:

· Dr Andy Palmer, President and Group Chief Executive Officer (CEO) - 262,135 shares (225% of salary)

· Mark Wilson, EVP and Chief Financial Officer (CFO) - 61,893 shares (150% of salary)

These LTIP awards are subject to the performance conditions, vesting and holding periods

and malus and clawback provisions set out below.

 

2019 Performance measures and targets:

2019 LTIP targets

Vesting*(as a % of maximum)

EPS(3Y CAGR)

(40% of award)

Threshold

45%

20%

Stretch

55%

70%

Maximum

65%

100%

ROIC

(% in FY21)(40% of award)

Threshold

14.6%

20%

Stretch

18.0%

70%

Maximum

20.0%

100%

Relative TSR

(vs. FTSE51-150)(20% of award)

Threshold

Median rank

20%

Maximum

Upper quartile rank

100%

Additional share price underpin on TSR elementof awards

Shares would not usually vest unless a share price of £19 is achieved between the end of the performance period and the end of the holding period.

* Vesting will be on a straight-line basis between each of threshold and stretch, and stretch and maximum (and threshold and maximum for the TSR element)

· The Remuneration Committee retains discretion to adjust the vesting levels to ensure they reflect underlying business performance and any other relevant factors

Vesting and holding period:

· Subject to performance, awards to vest 3 years from grant following the announcement of results for 2021 but subject to a further 2 year holding period post vest (net of tax)

· The CEO and CFO have volunteered to extend the existing (2-year) holding period on their 2019 LTIP awards, to not sell any of the shares, should they vest, from their 2019 awards until the Company's share price is at £19 or above.

Malus and Clawback:

· Malus and clawback provisions will be operated at the discretion of the Remuneration Committee in respect of the LTIP where it considers that there are exceptional circumstances. Such exceptional circumstances may include serious reputational damage, a failure of risk management, an error in available financial information, which led to the award being greater than it would otherwise have been or personal misconduct. Clawback may be applied for a period of up to three years for any LTIP awards.

 

The following disclosures are made in accordance with Article 19.3 of the EU Market Abuse Regulation 596/2014.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Dr Andy Palmer

2

Reason for the notification

a)

Position/status

President and Group Chief Executive Officer

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aston Martin Lagonda Global Holdings plc

b)

LEI

213800167WOVOK5ZC776

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrumentIdentification code

 

Ordinary Shares (ISIN: GB00BFXZC448)

b)

Nature of the transaction

Grant of a nil-cost option under the Aston Martin Lagonda Long-Term Incentive Plan 2018

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

262,135

d)

Aggregated information- Aggregated volume- Price

 

 

262,135

 

N/A

e)

Date of the transaction

27 June 2019

f)

Place of the transaction

Outside a Trading Venue

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mark Wilson

2

Reason for the notification

a)

Position/status

EVP and Chief Financial Officer

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aston Martin Lagonda Global Holdings plc

b)

LEI

213800167WOVOK5ZC776

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrumentIdentification code

Ordinary Shares (ISIN: GB00BFXZC448)

b)

Nature of the transaction

Grant of a nil-cost option under the Aston Martin Lagonda Long-Term Incentive Plan 2018

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

61,893

d)

Aggregated information- Aggregated volume- Price

 

 

61,893

 

N/A

e)

Date of the transaction

27 June 2019

f)

Place of the transaction

Outside a Trading Venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBUGDLLUDBGCR
Date   Source Headline
4th Jun 20267:00 amRNSIssue of equity to satisfy share awards
15th May 20267:00 amRNSIssue of equity to satisfy employee share awards
6th May 202612:51 pmRNSVoting results of AGM 2026
29th Apr 20267:00 amRNSQ1 results for three months ended 31 March 2026
25th Mar 20269:53 amRNSAnnual Financial Report
9th Mar 202612:12 pmRNSResult of Meeting
25th Feb 20267:00 amRNSPreliminary Results FY2025
20th Feb 20267:00 amRNSNotice of GM and FY 2025 Trading Update
29th Oct 20257:00 amRNSQ3 results for the quarter ended 30 September 2025
6th Oct 20257:00 amRNSQ3 2025 Trading Update and revised outlook
10th Sep 202511:33 amRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSIssue of equity to satisfy employee share awards
30th Jul 20257:00 amRNSInterim results
28th Jul 20254:33 pmRNSDirectorate Change
27th May 202510:13 amRNSDirector/PDMR Shareholding
27th May 202510:12 amRNSDirector/PDMR Shareholding
15th May 202510:38 amRNSHolding(s) in Company
13th May 20255:26 pmRNSHolding(s) in Company
13th May 202510:33 amRNSDirector/PDMR Shareholding
13th May 202510:31 amRNSDirector/PDMR Shareholding
13th May 202510:26 amRNSDirector/PDMR Shareholding
12th May 20255:53 pmRNSHolding(s) in Company
12th May 20251:13 pmRNSHolding(s) in Company
12th May 202512:52 pmRNSHolding(s) in Company
7th May 20252:45 pmRNSDirector/PDMR Shareholding
7th May 20251:15 pmRNSResult of General Meeting and issue of equity
7th May 20251:07 pmRNSVoting Result of AGM
30th Apr 20257:00 amRNS1st Quarter Results
17th Apr 20258:57 amRNSNotice of General Meeting
16th Apr 20253:20 pmRNSDirector Declaration
31st Mar 20255:11 pmRNSStatement regarding media comments
31st Mar 20257:00 amRNSProposed investment by Yew Tree Consortium
26th Mar 20259:24 amRNSAnnual Financial Report
26th Feb 20257:00 amRNSPreliminary results year ended 31 December 2024
25th Feb 202510:00 amRNSIndependent Non-executive Director appointment
7th Feb 20255:29 pmRNSHolding(s) in Company
13th Dec 20249:00 amRNSDirectorate Change
4th Dec 20244:00 pmRNSHolding(s) in Company
29th Nov 20244:15 pmRNSHolding(s) in Company
29th Nov 20241:01 pmRNSHolding(s) in Company
29th Nov 202412:46 pmRNSDirector/PDMR Shareholding Replacement
29th Nov 202412:18 pmRNSDirector/PDMR Shareholding
29th Nov 202412:17 pmRNSDirector/PDMR Shareholding
29th Nov 202412:11 pmRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSResult of Equity Issue
26th Nov 20245:06 pmRNSIssue of Equity
26th Nov 20244:58 pmRNSIssue of Equity
6th Nov 202410:37 amRNSDirector/PDMR Shareholding
30th Oct 20247:00 amRNS3rd Quarter Results
30th Sep 20247:00 amRNSTrading Update and adjustment to FY 2024 guidance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.